Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Rumina shares her mother's cancer journey (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases

Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/

Strategies for reducing excess body fat... - Jill Brook, MA (2021 Conference) (LDN, low dose naltrexone)

Cancer Case Studies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)

Cancer is a systemic disease. This presentation is on using low dose naltrexone (LDN) as a cancer treatment, looking at several case reports, diagnostic tests, and various therapies. Cases include breast cancer, nodular melanoma, and adenocarcinoma with lymphovascular invasion in a colonic polyp

Case Reports of Cancer Therapies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)

Dr. Khan believes in integrative care, combining allopathic and naturopathic therapies. They treat all types of cancer and people of all ages, with a focus on non-toxic therapy, and quality of life.

Opiate Receptor Drugs – To Cycle or Not to Cycle Dosing? - Paul Anderson, NMD (2021 Conference) (LDN, low dose naltrexone)

The role of immune modulation in cancer - Professor Angus Dalgleish (2021 Conference) (LDN, low dose naltrexone)

Angus Dalgleish, MD - The Role of Non-Cytotoxic Drugs in the Management of Cancer (2017 Conference) (LDN, low dose naltrexone)